Sustained macrophage reprogramming is required for CD8+ T cell-dependent long-term tumor eradication.

Researchers uncovered the vulnerability of transient tumor-associated macrophages reprogramming and show that it can be overcome by repeated myeloid cell treatment administrations to sustain efficient antitumor immune responses.